Neurology & Neurotherapeutics - NE Movement Disorders Section

Research output

Research output per year 1989 1998 2002 2003 2004 2007 2008 2014 2016 2017 2020 2021 2022 2023 2024

• 123 Article
• 18 Review article
• 5 Chapter
• 5 Editorial
• 10 More
  • 4 Comment/debate
  • 4 Letter
  • 2 Conference contribution

Research output per year

Research output per year

Search results

• 2024

  Longitudinal prognosis of Parkinson's outcomes using causal connectivity

  Mellema, C. J., Nguyen, K. P., Treacher, A., Andrade, A. X., Pouratian, N., Sharma, V. D., O'Suileabhain, P. & Montillo, A. A., Jan 2024, In: NeuroImage: Clinical. 42, 103571.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Parkinson Disease 100%
  • Progressive Supranuclear Palsy 63%
  • Multiple System Atrophy 63%
  • Cognitive Dysfunction 39%
  • Parkinson Disease, Familial, Type 1 37%
• 2023

  Early-onset Parkinson's disease: An assessment of unmet psychosocial needs

  McDaniels, B., Subramanian, I., Kurian, S. & Chitnis, S., May 2023, In: Parkinsonism and Related Disorders. 110, 105395.

  Research output: Contribution to journal › Article › peer-review

  • Hispanic Americans 100%
  • Parkinson Disease 87%
  • Quality of Life 33%
  • Population 30%
  • Chi-Square Distribution 25%
  1 Scopus citations

• Genome-wide structural variant analysis identifies risk loci for non-Alzheimer's dementias

  PROSPECT Consortium, The American Genome Center, International LBD Genomics Consortium & International ALS/FTD Consortium, Jun 14 2023, In: Cell Genomics. 3, 6, 100316.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Genomic Structural Variation 100%
  • Frontotemporal Dementia With Motor Neuron Disease 92%
  • Lewy Body Disease 76%
  • Pipeline 69%
  • Dementia 50%
  5 Scopus citations

• Improving tremor response to focused ultrasound thalamotomy

  Holcomb, J. M., Chopra, R., Feltrin, F. S., Elkurd, M., El-Nazer, R., Mckenzie, L., O'suilleabhain, P., Maldjian, J. A., Dauer, W. & Shah, B. R., 2023, In: Brain Communications. 5, 4, fcad165.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Tremor 100%
  • Essential Tremor 27%
  • Sonication 26%
  • Pyramidal Tracts 25%
  • Thalamus 20%
  3 Scopus citations

• Neuronal activity regulates Matrin 3 abundance and function in a calcium-dependent manner through calpain-mediated cleavage and calmodulin binding

  Malik, A. M., Wu, J. J., Gillies, C. A., Doctrove, Q. A., Li, X., Huang, H., Tank, E. H. M., Shakkottai, V. G. & Barmada, S., Apr 11 2023, In: Proceedings of the National Academy of Sciences of the United States of America. 120, 15, e2206217120.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Calpain 100%
  • Calmodulin 89%
  • RNA-Binding Proteins 56%
  • Calcium 55%
  • Amyotrophic Lateral Sclerosis 52%
  1 Scopus citations

• SCAview: an Intuitive Visual Approach to the Integrative Analysis of Clinical Data in Spinocerebellar Ataxias

  EUROSCA study group, ESMI study group, RISCA study group, CRC-SCA study group & SCA Registry study group, 2023, (Accepted/In press) In: Cerebellum.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Spinocerebellar Ataxias 100%
  • Data Analysis 55%
  • Datasets 43%
  • Information Storage and Retrieval 33%
  • Data Visualization 27%

• The S-Factor, a New Measure of Disease Severity in Spinocerebellar Ataxia: Findings and Implications

  Selvadurai, L. P., Perlman, S. L., Wilmot, G. R., Subramony, S. H., Gomez, C. M., Ashizawa, T., Paulson, H. L., Onyike, C. U., Rosenthal, L. S., Sair, H. I., Kuo, S. H., Ratai, E. M., Zesiewicz, T. A., Bushara, K. O., Öz, G., Dietiker, C., Geschwind, M. D., Nelson, A. B., Opal, P., Yacoubian, T. A., & 6 othersNopoulos, P. C., Shakkottai, V. G., Figueroa, K. P., Pulst, S. M., Morrison, P. E. & Schmahmann, J. D., Oct 2023, In: Cerebellum. 22, 5, p. 790-809 20 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Spinocerebellar Ataxias 100%
  • Ataxia 78%
  • Natural History 14%
  • Age of Onset 13%
  • Neurodegenerative Diseases 12%
  5 Scopus citations
• 2022

  APDM gait and balance measures fail to predict symptom progression rate in Parkinson's disease

  Dewey, D. C., Chitnis, S., McCreary, M. C., Gerald, A., Dewey, C. H., Pantelyat, A., Dawson, T. M., Rosenthal, L. S. & Dewey, R. B., Nov 9 2022, In: Frontiers in Neurology. 13, 1041014.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Gait 100%
  • Parkinson Disease 87%
  • propylene diquat 41%
  • Levodopa 29%
  • Mental Status and Dementia Tests 27%

• Difficulties translating antisense-mediated activation of Frataxin expression from cell culture to mice

  Kilikevicius, A., Wang, J., Shen, X., Rigo, F., Prakash, T. P., Napierala, M. & Corey, D. R., 2022, In: RNA Biology. 19, 1, p. 364-372 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • frataxin 100%
  • Cell Culture Techniques 49%
  • Friedreich Ataxia 38%
  • Oligonucleotides 28%
  • Nuclear RNA 12%
  3 Scopus citations

• Discovery of Novel Activators of Large-Conductance Calcium-Activated Potassium Channels for the Treatment of Cerebellar Ataxia^S

  Srinivasan, S. R., Huang, H., Chang, W. C., Nasburg, J., Nguyen, H., Strassmaier, T., Wulff, H. & Shakkottai, V. G., Jul 1 2022, In: Molecular Pharmacology. 102, 1, p. 17-28 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Large-Conductance Calcium-Activated Potassium Channels 100%
  • Cerebellar Ataxia 89%
  • Spinocerebellar Ataxias 29%
  • Purkinje Cells 24%
  • Drug Discovery 14%
  9 Scopus citations

• Focused ultrasound using a novel targeting method four-tract tractography for magnetic resonance-guided high-intensity focused ultrasound targeting

  Feltrin, F. S., Chopra, R., Pouratian, N., Elkurd, M., El-Nazer, R., Lanford, L., Dauer, W. & Shah, B. R., 2022, In: Brain Communications. 4, 6, fcac273.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Magnetic Resonance Spectroscopy 100%
  • United States Food and Drug Administration 78%
  • Essential Tremor 53%
  • Ventral Thalamic Nuclei 52%
  • Pyramidal Tracts 48%
  9 Scopus citations

• Genetic evaluation of dementia with Lewy bodies implicates distinct disease subgroups

  Kaivola, K., Shah, Z., Chia, R., Black, S. E., Gan-Or, Z., Keith, J., Masellis, M., Rogaeva, E., Brice, A., Lesage, S., Xiromerisiou, G., Calvo, A., Canosa, A., Chio, A., Logroscino, G., Mora, G., Krüger, R., May, P., Alcolea, D., Clarimon, J., & 66 othersFortea, J., Gonzalez-Aramburu, I., Infante, J., Lage, C., Lleó, A., Pastor, P., Sanchez-Juan, P., Brett, F., Aarsland, D., Al-Sarraj, S., Attems, J., Gentleman, S., Hardy, J. A., Hodges, A. K., Love, S., Mckeith, I. G., Morris, C. M., Morris, H. R., Palmer, L., Pickering-Brown, S., Ryten, M., Thomas, A. J., Troakes, C., Albert, M. S., Barrett, M. J., Beach, T. G., Bekris, L. M., Bennett, D. A., Boeve, B. F., Dalgard, C. L., Dawson, T. M., Dickson, D. W., Faber, K., Ferman, T., Ferrucci, L., Flanagan, M. E., Foroud, T. M., Ghetti, B., Gibbs, J. R., Goate, A., Goldstein, D. S., Graff-Radford, N. R., Kaufmann, H., Kukull, W. A., Leverenz, J. B., Mao, Q., Masliah, E., Monuki, E., Newell, K. L., Palma, J. A., Pletnikova, O., Renton, A. E., Resnick, S. M., Rosenthal, L. S., Ross, O. A., Scherzer, C. R., Serrano, G. E., Shakkottai, V. G., Sidransky, E., Tanaka, T., Topol, E., Torkamani, A., Troncoso, J. C., Woltjer, R., Wszolek, Z. K. & Scholz, S. W., May 1 2022, In: Brain. 145, 5, p. 1757-1762 6 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Lewy Body Disease 100%
  • Alzheimer Disease 35%
  • Pathology 20%
  • Synucleins 19%
  • Lewy Bodies 8%
  10 Scopus citations

• Plasma MIA, CRP, and Albumin Predict Cognitive Decline in Parkinson's Disease

  Shen, J., Amari, N., Zack, R., Skrinak, R. T., Unger, T. L., Posavi, M., Tropea, T. F., Xie, S. X., Van Deerlin, V. M., Dewey, R. B., Weintraub, D., Trojanowski, J. Q. & Chen-Plotkin, A. S., Aug 2022, In: Annals of Neurology. 92, 2, p. 255-269 15 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Protein C 100%
  • C-Reactive Protein 78%
  • Albumins 76%
  • Parkinson Disease 74%
  • Melanoma 73%
  7 Scopus citations

• Preliminary Study of Vibrotactile Feedback during Home-Based Balance and Coordination Training in Individuals with Cerebellar Ataxia

  Jabri, S., Bushart, D. D., Kinnaird, C., Bao, T., Bu, A., Shakkottai, V. G. & Sienko, K. H., May 1 2022, In: Sensors. 22, 9, 3512.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • ataxia 100%
  • Cerebellar Ataxia 68%
  • Ataxia 57%
  • education 53%
  • Spinocerebellar Degenerations 47%
  2 Scopus citations

• Through the Looking Glass: Remote Versus In-Person Videotaped Neurologic Assessment of Essential Tremor

  Newton, D., McGurn, M., Hernandez, D. I., Hernandez, N. C., Elkurd, M. & Louis, E. D., Jan 2022, In: Movement Disorders Clinical Practice. 9, 1, p. 87-90 4 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Essential Tremor 100%
  • Tremor 79%
  • Glass 71%
  • Nervous System 60%
  • Videotape Recording 15%

• Viewpoint on Milestones for Fellowship Training in Movement Disorders

  Ratliff, J. B., Schaefer, S. M., Chitnis, S., Cooney, J. W., Hess, C. W., Okubadejo, N., Shalash, A., Moro, E., Sue, C., Pandey, S., Pal, P. K. & Yang, L., Aug 2022, In: Movement Disorders. 37, 8, p. 1605-1609 5 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  2 Scopus citations
• 2021

  Dysarthria treatment for Parkinson’s disease: one-year follow-up of SPEAK OUT!^® with the LOUD Crowd^®

  Behrman, A., Cody, J., Chitnis, S. & Elandary, S., 2021, (Accepted/In press) In: Logopedics Phoniatrics Vocology.

  Research output: Contribution to journal › Article › peer-review

  • Parkinson's Disease 100%
  • Dysarthria 90%
  • Crowds 58%
  • Parkinson Disease 47%
  • Speech Therapy 41%
  2 Scopus citations

• Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial

  Schwarzschild, M. A., Ascherio, A., Casaceli, C., Curhan, G. C., Fitzgerald, R., Kamp, C., Lungu, C., Macklin, E. A., Marek, K., Mozaffarian, D., Oakes, D., Rudolph, A., Shoulson, I., Videnovic, A., Scott, B., Gauger, L., Aldred, J., Bixby, M., Ciccarello, J., Gunzler, S. A., & 84 othersHenchcliffe, C., Brodsky, M., Keith, K., Hauser, R. A., Goetz, C., Ledoux, M. S., Hinson, V., Kumar, R., Espay, A. J., Jimenez-Shahed, J., Hunter, C., Christine, C., Daley, A., Leehey, M., De Marcaida, J. A., Friedman, J. H., Hung, A., Bwala, G., Litvan, I., Simon, D. K., Simuni, T., Poon, C., Schiess, M. C., Chou, K., Park, A., Bhatti, D., Peterson, C., Criswell, S. R., Rosenthal, L., Durphy, J., Shill, H. A., Mehta, S. H., Ahmed, A., Deik, A. F., Fang, J. Y., Stover, N., Zhang, L., Dewey, R. B., Gerald, A., Boyd, J. T., Houston, E., Suski, V., Mosovsky, S., Cloud, L., Shah, B. B., Saint-Hilaire, M., James, R., Zauber, S. E., Reich, S., Shprecher, D., Pahwa, R., Langhammer, A., Lafaver, K., Lewitt, P. A., Kaminski, P., Goudreau, J., Russell, D., Houghton, D. J., Laroche, A., Thomas, K., McGraw, M., Mari, Z., Serrano, C., Blindauer, K., Rabin, M., Kurlan, R., Morgan, J. C., Soileau, M., Ainslie, M., Bodis-Wollner, I., Schneider, R. B., Waters, C., Ratel, A. S., Beck, C. A., Bolger, P., Callahan, K. F., Crotty, G. F., Klements, D., Kostrzebski, M., McMahon, G. M., Pothier, L., Waikar, S. S., Lang, A. & Mestre, T., Sep 14 2021, In: JAMA - Journal of the American Medical Association. 326, 10, p. 926-939 14 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Inosine 100%
  • Uric Acid 75%
  • Parkinson Disease 62%
  • Disease Progression 59%
  • Randomized Controlled Trials 50%
  79 Scopus citations

• Lateralization of Motor Signs Affects Symptom Progression in Parkinson Disease

  Elkurd, M., Wang, J. & Dewey, R. B., Jul 27 2021, In: Frontiers in Neurology. 12, 711045.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Movement Disorders 100%
  • Mental Status and Dementia Tests 93%
  • Signs and Symptoms 77%
  • Parkinson Disease 75%
  • National Institute of Neurological Disorders and Stroke (U.S.) 22%
  7 Scopus citations

• Management of Parkinson's Disease during the COVID-19 Pandemic: Challenges and Opportunities

  McDaniels, B., Braitsch, M., Novak, D. & Chitnis, S., Jan 1 2021, In: Journal of Rehabilitation. 87, 1, p. 71-79 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Pandemics 100%
  • Parkinson Disease 78%
  • management 44%
  • Healthcare 20%
  • Exercise 20%

• Oral Levodopa Formulation Does Not Affect Progression of Parkinson Disease

  Sethi, A., Dilwali, S., McCreary, M. & Dewey, R. B., 2021, In: Clinical neuropharmacology. 44, 2, p. 47-52 6 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • levodopa drug combination carbidopa 100%
  • Levodopa 75%
  • Parkinson Disease 56%
  • entacapone 44%
  • Mental Status and Dementia Tests 14%
  1 Scopus citations

• Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis

  The PROSPECT Consortium, The American Genome Center (TAGC), The FALS Sequencing Consortium, The Genomics England Research Consortium, The International ALS/FTD Genomics Consortium (iAFGC), The International FTD Genetics Consortium (IFGC), The International LBD Genomics Consortium (iLBDGC), The NYGC ALS Consortium & the University of Maryland Brain and Tissue Bank and NIH NeuroBioBank, Feb 3 2021, In: Neuron. 109, 3, p. 448-460.e4

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Frontotemporal Dementia With Motor Neuron Disease 100%
  • Lewy Body Disease 23%
  • Huntington Disease 10%
  • Genetic Testing 9%
  • Ubiquitin 9%
  54 Scopus citations

• Predicting Parkinson's disease trajectory using clinical and neuroimaging baseline measures

  Nguyen, K. P., Raval, V., Treacher, A., Mellema, C., Yu, F. F., Pinho, M. C., Subramaniam, R. M., Dewey, R. B. & Montillo, A. A., Apr 2021, In: Parkinsonism and Related Disorders. 85, p. 44-51 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Movement Disorders 100%
  • Mental Status and Dementia Tests 93%
  • Neuroimaging 81%
  • Parkinson Disease 75%
  • Biomarkers 38%
  15 Scopus citations

• Probable REM Sleep Behavior Disorder Is a Risk Factor for Symptom Progression in Parkinson Disease

  Barasa, A., Wang, J. & Dewey, R. B., Apr 7 2021, In: Frontiers in Neurology. 12, 651157.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • REM Sleep Behavior Disorder 100%
  • Parkinson Disease 58%
  • Movement Disorders 33%
  • Mental Status and Dementia Tests 31%
  • propylene diquat 15%
  6 Scopus citations

• THAP1 modulates oligodendrocyte maturation by regulating ECM degradation in lysosomes

  Yellajoshyula, D., Pappas, S. S., Rogers, A. E., Choudhury, B., Reed, X., Ding, J., Cookson, M. R., Shakkottai, V. G., Giger, R. J. & Dauer, W. T., Aug 3 2021, In: Proceedings of the National Academy of Sciences of the United States of America. 118, 31, e2100862118.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Oligodendroglia 100%
  • Glycosaminoglycans 96%
  • Lysosomes 92%
  • Oligodendrocyte Precursor Cells 90%
  • Extracellular Matrix 76%
  5 Scopus citations

• The spiral axis: A comparison of unaffected first-degree relatives of essential tremor cases vs. controls

  Louis, E. D., Dowd, H. N. & Elkurd, M., Mar 15 2021, In: Journal of the Neurological Sciences. 422, 117330.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Essential Tremor 100%
  • Tremor 15%
  • Dystonia 8%
  • Movement Disorders 8%
  • Neurologists 8%
  2 Scopus citations
• 2020

  Cognitive impairment and dementia in parkinson’s disease

  Elkurd, M. T. & Dewey, R. B., Mar 2020, In: Psychiatric Annals. 50, 3, p. 100-106 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Parkinson Disease 100%
  • Dementia 99%
  • Cognitive Dysfunction 97%
  • Lewy Body Disease 18%
  • Pathology 18%

• Lack of Accredited Clinical Training in Movement Disorders in Europe, Egypt, and Tunisia

  Tamás, G., Fabbri, M., Falup-Pecurariu, C., Teodoro, T., Kurtis, M. M., Aliyev, R., Bonello, M., Brozova, H., Coelho, M. S., Contarino, M. F., Corvol, J. C., DIetrichs, E., Ben Djebara, M., Elmgreen, S. B., Groppa, S., Kadastik-Eerme, L., Khatiashvili, I., Kostić, V., Krismer, F., Hassan Mansour, A., & 15 othersOdin, P., Gavriliuc, O., Olszewska, DI. A., Relja, M., Scheperjans, F., Skorvanek, M., Smilowska, K., Taba, P., Tavadyan, Z., Valante, R., Vujovic, B., Waldvogel, D., Yalcin-Cakmakli, G., Chitnis, S. & Ferreira, J. J., 2020, In: Journal of Parkinson's Disease. 10, 4, p. 1833-1843 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Tunisia 100%
  • Egypt 90%
  • Movement Disorders 84%
  • Neurology 44%
  • Northern Africa 11%
  5 Scopus citations

• Patient perceptions and knowledge of Parkinson's disease and treatment (KnowPD)

  Salinas, M. R., Chambers, E. J., Ho, T., Khemani, P., Olson, D. W. M., Stutzman, S. & Chitnis, S., 2020, In: Clinical Parkinsonism and Related Disorders. 3, 100038.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Parkinson Disease 100%
  • Deep Brain Stimulation 39%
  • Levodopa 37%
  • Lunch 21%
  • Health Literacy 21%
  10 Scopus citations

• Safety and tolerability of srx246, a vasopressin 1a antagonist, in irritable huntington’s disease patients—a randomized phase 2 clinical trial

  Brownstein, M. J., Simon, N. G., Long, J. D., Yankey, J., Maibach, H. T., Cudkowicz, M., Coffey, C., Conwit, R. A., Lungu, C., Anderson, K. E., Hersch, S. M., Ecklund, D. J., Damiano, E. M., Itzkowitz, D. E., Lu, S., Chase, M. K., Shefner, J. M., McGarry, A., Thornell, B., Gladden, C., & 46 othersCostigan, M., O’suilleabhain, P., Marshall, F. J., Chesire, A. M., Deritis, P., Adams, J. L., Hedera, P., Lowen, K., Diana Rosas, H., Hiller, A. L., Quinn, J., Keith, K., Duker, A. P., Gruenwald, C., Molloy, A., Jacob, C., Factor, S., Sperin, E., Bega, D., Brown, Z. R., Seeberger, L. C., Sung, V. W., Benge, M., Kostyk, S. K., Daley, A. M., Perlman, S., Suski, V., Conlon, P., Barrett, M. J., Lowenhaupt, S., Quigg, M., Perlmutter, J. S., Wright, B. A., Most, E., Schwartz, G. J., Lamb, J., Chuang, R. S., Singer, C., Marder, K., Moran, J. A., Singleton, J. R., Zorn, M., Wall, P. V., Dubinsky, R. M., Gray, C. & Drazinic, C., Nov 2020, In: Journal of Clinical Medicine. 9, 11, p. 1-14 14 p., 3682.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • SRX246 100%
  • Antidiuretic Hormone Receptor Antagonists 57%
  • Huntington Disease 44%
  • Clinical Trials 26%
  • Safety 23%
  13 Scopus citations

• The effect of speak out! and the loud crowd on dysarthria due to parkinson’s disease

  Behrman, A., Cody, J., Elandary, S., Flom, P. & Chitnis, S., Aug 2020, In: American Journal of Speech-Language Pathology. 29, 3, p. 1448-1465 18 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Parkinson's Disease 100%
  • Dysarthria 90%
  • Crowds 58%
  • Monologue 53%
  • Reading 49%
  19 Scopus citations
• 2019

  Characterization of Parkinson's disease using blood-based biomarkers: A multicohort proteomic analysis

  Posavi, M., Diaz-Ortiz, M., Liu, B., Swanson, C. R., Skrinak, R. T., Hernandez-Con, P., Amado, D. A., Fullard, M., Rick, J., Siderowf, A., Weintraub, D., McCluskey, L., Trojanowski, J. Q., Dewey, R. B., Huang, X. & Chen-Plotkin, A. S., 2019, In: PLoS Medicine. 16, 10, e1002931.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Proteomics 100%
  • Parkinson Disease 91%
  • Biomarkers 70%
  • Proteins 21%
  • osteoadherin 19%
  38 Scopus citations

• Functional motor control deficits in older FMR1 premutation carriers

  Park, S. H., Wang, Z., McKinney, W., Khemani, P., Lui, S., Christou, E. A. & Mosconi, M. W., Sep 1 2019, In: Experimental Brain Research. 237, 9, p. 2269-2278 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Fragile X Tremor Ataxia Syndrome 100%
  • Intellectual Disability 86%
  • Fingers 27%
  • Advisory Committees 16%
  • Aptitude 10%
  7 Scopus citations

• Precision Sensorimotor Control in Aging FMR1 Gene Premutation Carriers

  McKinney, W. S., Wang, Z., Kelly, S., Khemani, P., Lui, S., White, S. P. & Mosconi, M. W., Oct 2 2019, In: Frontiers in Integrative Neuroscience. 13, 56.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Fragile X Tremor Ataxia Syndrome 100%
  • Guanine 72%
  • Cytosine 36%
  • Reaction Time 28%
  • Genes 24%
  9 Scopus citations

• Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trial

  Boxer, A. L., Qureshi, I., Ahlijanian, M., Grundman, M., Golbe, L. I., Litvan, I., Honig, L. S., Tuite, P., McFarland, N. R., O'Suilleabhain, P., Xie, T., Tirucherai, G. S., Bechtold, C., Bordelon, Y., Geldmacher, D. S., Grossman, M., Isaacson, S., Zesiewicz, T., Olsson, T., Muralidharan, K. K., & 4 othersGraham, D. L., O'Gorman, J., Haeberlein, S. B. & Dam, T., Jun 2019, In: The Lancet Neurology. 18, 6, p. 549-558 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Progressive Supranuclear Palsy 100%
  • Monoclonal Antibodies 54%
  • Placebos 51%
  • Safety 43%
  • Urinary Tract Infections 23%
  102 Scopus citations

• Static and dynamic postural control deficits in aging fragile X mental retardation 1 (FMR1) gene premutation carriers

  Wang, Z., Khemani, P., Schmitt, L. M., Lui, S. & Mosconi, M. W., Jan 21 2019, In: Journal of neurodevelopmental disorders. 11, 1, 2.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Fragile X Tremor Ataxia Syndrome 100%
  • Postural Balance 73%
  • Intellectual Disability 57%
  • Genes 24%
  • Direction compound 10%
  11 Scopus citations
• 2018

  Charcot Marie Tooth disease type 4J with complex central nervous system features

  Orengo, J. P., Khemani, P., Day, J. W., Li, J. & Siskind, C. E., Feb 2018, In: Annals of Clinical and Translational Neurology. 5, 2, p. 222-225 4 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Type 4j Charcot-Marie-Tooth Disease 100%
  • Central Nervous System 33%
  • Charcot-Marie-Tooth Disease 20%
  • Parkinsonian Disorders 16%
  • Genetic Testing 15%
  14 Scopus citations

• Deep brain stimulation and sleep-wake disturbances in parkinson disease: A review

  Sharma, V. D., Sengupta, S., Chitnis, S. & Amara, A. W., Aug 27 2018, In: Frontiers in Neurology. 9, AUG, 697.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Deep Brain Stimulation 100%
  • Parkinson Disease 72%
  • Sleep 66%
  • Subthalamic Nucleus 8%
  • Globus Pallidus 7%
  36 Scopus citations

• Metastatic "burned out" seminoma causing neurological paraneoplastic syndrome-not quite "burned out"

  Freifeld, Y., Kapur, P., Chitkara, R., Lee, F., Khemani, P. & Bagrodia, A., Jan 30 2018, In: Frontiers in Neurology. 9, JAN, 20.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Paraneoplastic Syndromes 100%
  • Seminoma 95%
  • Cerebellar Ataxia 94%
  • Germ Cell and Embryonal Neoplasms 88%
  • Limbic Encephalitis 57%
  9 Scopus citations
• 2017

  A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease

  McGarry, A., McDermott, M., Kieburtz, K., DeBlieck, E. A., Beal, F., Marder, K., Ross, C., Shoulson, I., Gilbert, P., Mallonee, W. M., Guttman, M., Wojcieszek, J., Kumar, R., LeDoux, M. S., Jenkins, M., Rosas, H. D., Nance, M., Biglan, K., Como, P., Dubinsky, R. M., & 40 othersShannon, K. M., O'Suilleabhain, P., Chou, K., Walker, F., Martin, W., Wheelock, V. L., McCusker, E., Jankovic, J., Singer, C., Sanchez-Ramos, J., Scott, B., Suchowersky, O., Factor, S. A., Higgins, D. S., Molho, E., Revilla, F., Caviness, J. N., Friedman, J. H., Perlmutter, J. S., Feigin, A., Anderson, K., Rodriguez, R., McFarland, N. R., Margolis, R. L., Farbman, E. S., Raymond, L. A., Suski, V., Kostyk, S., Colcher, A., Seeberger, L., Epping, E., Esmail, S., Diaz, N., Alan Fung, W. L., Diamond, A., Frank, S., Hanna, P., Hermanowicz, N., Dure, L. S. & Cudkowicz, M., Jan 10 2017, In: Neurology. 88, 2, p. 152-159 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • coenzyme Q10 100%
  • Huntington Disease 84%
  • Placebos 52%
  • Medical Futility 21%
  • Psychological Power 14%
  98 Scopus citations

• Caffeine, creatine, GRIN2A and Parkinson's disease progression

  Simon, D. K., Wu, C., Tilley, B. C., Lohmann, K., Klein, C., Payami, H., Wills, A. M., Aminoff, M. J., Bainbridge, J., Dewey, R., Hauser, R. A., Schaake, S., Schneider, J. S., Sharma, S., Singer, C., Tanner, C. M., Truong, D., Wei, P., Wong, P. S. & Yang, T., Apr 15 2017, In: Journal of the Neurological Sciences. 375, p. 355-359 5 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Creatine 100%
  • Caffeine 88%
  • Parkinson Disease 70%
  • Disease Progression 67%
  • Genotype 26%
  24 Scopus citations
• 2016

  Blood biomarker for Parkinson disease: peptoids

  Yazdani, U., Zaman, S., Hynan, L. S., Brown, L. S., Dewey, R. B., Karp, D. & German, D. C., Dec 1 2016, In: npj Parkinson's Disease. 2, 1, 16012.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Peptoids 100%
  • Parkinson Disease 47%
  • Biomarkers 36%
  • Synucleins 7%
  • Immunoglobulin G 7%
  15 Scopus citations

• Cystic Lesions as a Rare Complication of Deep Brain Stimulation

  Sharma, V. D., Bona, A. R., Mantovani, A., Miocinovic, S., Khemani, P., Goldberg, M. P., Foote, K. D., Whitworth, L. A., Chitnis, S. & Okun, M. S., Jan 1 2016, In: Movement Disorders Clinical Practice. 3, 1, p. 87-90 4 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Essential Tremor 100%
  • Deep Brain Stimulation 86%
  • Ventral Thalamic Nuclei 49%
  • Internal Capsule 48%
  • Dystonia 43%
  8 Scopus citations

• Developing a deep brain stimulation neuromodulationnetwork for Parkinson disease, essential tremor, and dystonia: Report of a quality improvement project

  Dewey, R. B., O'Suilleabhain, P. E., Sanghera, M., Patel, N., Khemani, P., Lacritz, L. H., Chitnis, S. & Whitworth, L. A., Oct 2016, In: PloS one. 11, 10, e0164154.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Essential Tremor 100%
  • Dystonia 87%
  • Deep Brain Stimulation 86%
  • Quality Improvement 72%
  • Parkinson Disease 62%
  3 Scopus citations

• Duration of disease does not equally influence all aspects of quality of life in Parkinson's disease

  Benge, J. F., Kekecs, Z., Encarnacion, E., Ainslie, M., Herff, C., Elkins, G. & Herath, P., Jun 1 2016, In: Journal of Clinical Neuroscience. 28, p. 102-106 5 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Parkinson Disease 100%
  • Quality of Life 76%
  • propylene diquat 26%
  • Research Personnel 11%
  • Regression Analysis 11%
  6 Scopus citations

• The NINDS Parkinson's disease biomarkers program

  Rosenthal, L. S., Drake, D., Alcalay, R. N., Babcock, D., Bowman, F. D., Chen-Plotkin, A., Dawson, T. M., Dewey, R. B., German, D. C., Huang, X., Landin, B., Mcauliffe, M., Petyuk, V. A., Scherzer, C. R., Hillaire-Clarke, C. S., Sieber, B. A., Sutherland, M., Tarn, C., West, A., Vaillancourt, D., & 2 othersZhang, J. & Gwinn, K., Jun 1 2016, In: Movement Disorders. 31, 6, p. 915-923 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • National Institute of Neurological Disorders and Stroke (U.S.) 100%
  • Parkinson Disease 56%
  • Biomarkers 43%
  • Cerebrospinal Fluid 13%
  • Essential Tremor 10%
  69 Scopus citations

• Use of the Montreal Cognitive Assessment and Alzheimer's Disease-8 as cognitive screening measures in Parkinson's disease

  Brown, D. S., Bernstein, I. H., McClintock, S. M., Munro Cullum, C., Dewey, R. B., Husain, M. & Lacritz, L. H., Mar 1 2016, In: International Journal of Geriatric Psychiatry. 31, 3, p. 264-272 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Alzheimer Disease 8 100%
  • Mental Status and Dementia Tests 59%
  • Parkinson Disease 47%
  • Cognitive Dysfunction 39%
  • Sensitivity and Specificity 21%
  18 Scopus citations
• 2015

  Effect of creatine monohydrate on clinical progression in patients with parkinson disease: A randomized clinical trial

  Kieburtz, K., Tilley, B. C., Elm, J. J., Babcock, D., Hauser, R., Ross, G. W., Augustine, A. H., Augustine, E. U., Aminoff, M. J., Bodis-Wollner, I. G., Boyd, J., Cambi, F., Chou, K., Christine, C. W., Cines, M., Dahodwala, N., Derwent, L., Dewey, R. B., Hawthorne, K., Houghton, D. J., & 23 othersKamp, C., Leehey, M., Lew, M. F., Lin Liang, G. S., Luo, S. T., Mari, Z., Morgan, J. C., Parashos, S., Pérez, A., Petrovitch, H., Rajan, S., Reichwein, S., Roth, J. T., Schneider, J. S., Shannon, K. M., Simon, D. K., Simuni, T., Singer, C., Sudarsky, L., Tanner, C. M., Umeh, C. C., Williams, K. & Wills, A. M., Feb 10 2015, In: JAMA - Journal of the American Medical Association. 313, 6, p. 584-593 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Creatine 100%
  • Parkinson Disease 70%
  • Randomized Controlled Trials 56%
  • Placebos 48%
  • propylene diquat 22%
  166 Scopus citations

• Pioglitazone in early Parkinson's disease: A phase 2, multicentre, double-blind, randomised trial

  Simuni, T., Kieburtz, K., Tilley, B., J Elm, J., Ravina, B., Babcock, D., Emborg, M., Hauser, R., Kamp, C., Morgan, J. C., Webster Ross, G., K Simon, D., Bainbridge, J., Baker, L., Bodis-Wollner, I., Boyd, J., Cambi, F., Carter, J., Chou, K., Dahodwala, N., & 28 othersDewey, R. B., Dhall, R., Fang, J., Farrow, B., Feigin, A., Glazman, S., Goudreau, J., LeBlanc, P., Lee, S., Leehey, M., Lew, M. F., Lowenhaupt, S., Luo, S., Pahwa, R., Perez, A., Schneider, J., Scott, B., Shah, B., Shannon, K. M., Sharma, S., Singer, C., Truong, D., Wagner, R., Williams, K., Marie Wills, A., Shieen Wong, P., Zadikoff, C. & Zweig, R., Aug 1 2015, In: The Lancet Neurology. 14, 8, p. 795-803 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Pioglitazone 100%
  • Parkinson Disease 66%
  • Placebos 54%
  • Medical Futility 49%
  • Mental Status and Dementia Tests 27%
  201 Scopus citations

• The spectrum of autoimmune encephalopathies

  Dubey, D., Sawhney, A., Greenberg, B., Lowden, A., Warnack, W., Khemani, P., Stuve, O. & Vernino, S., Oct 15 2015, In: Journal of Neuroimmunology. 287, p. 93-97 5 p., 476194.

  Research output: Contribution to journal › Article › peer-review

  • Hashimoto's encephalitis 100%
  • Brain Diseases 64%
  • Immunomodulation 39%
  • Teaching Hospitals 15%
  • Clinical Studies 11%
  36 Scopus citations